Canada markets open in 2 hours 34 minutes

PCI Biotech Holding ASA (PCIB.OL)

Oslo - Oslo Delayed Price. Currency in NOK
Add to watchlist
16.30+0.19 (+1.18%)
As of 12:10PM CEST. Market open.
Full screen
Previous Close16.11
Bid16.30 x 20000
Ask16.37 x 12500
Day's Range16.25 - 16.90
52 Week Range15.20 - 47.75
Avg. Volume95,283
Market Cap608.42M
Beta (5Y Monthly)0.67
PE Ratio (TTM)N/A
EPS (TTM)-2.40
Earnings DateNov. 17, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    PCI Biotech: Employee share option scheme

    Oslo, 6 September 2021 In accordance with the authorisation granted and the remuneration policy adopted by the Annual General Meeting 28 May 2021, the Board of Directors of PCI Biotech Holding ASA (“PCI Biotech”) has awarded a total of 485,000 share options to key employees. Each share option gives the right to subscribe for or acquire one share per option (after PCI Biotech’s choice), at a strike price of NOK 19.41, equal to the volume weighted average share price (VWAP) for the last 5 days of

  • GlobeNewswire

    PCI Biotech first half-year 2021 interim results

    Oslo (Norway), 31 August 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first half-year 2021 results. Please find enclosed the report and presentation.Highlights fimaChem*The implementation of the amended protocol and the opening of Asian sites provided increased screening and enrolment to RELEASE in Q1, but the activity declined significantly in Q2 with only three patients included. The expected timeline for the interim analysis for poten

  • GlobeNewswire

    PCI Biotech: Invitation to first half-year 2021 result presentation

    Oslo, Norway, 23 August 2021 - PCI Biotech’s (OSE: PCIB) first half-year 2021 interim report will be released on 31 August 2021 at 07.00 CEST. The interim report and presentation will be made available on and on the company's webpage, A results presentation (in English) will be held through a live webcast at 08.30 CEST the same day. The webcast can be accessed through There will be a Q&A session at the end of the presentation. It will be pos